Projecte COIP.

Canvis en les isoformes de grelina i la microbiota en relació a la gastrectomia vertical i a la presència de Helicobacter Pylori. Instituto de Salud Carlos III. (Instituto de Salud Carlos III). 01/01/2018-30/06/2023.

COL.

Modifica la cirurgia la Malaltia del Fetge Gras no alcohòlic a través dels canvis induïts en la microbiota? FUNSECO. SOCIEDAD ESPAÑOLA DE CIRUGÍA DE LA OBESIDAD. (Sociedad Española de Cirugía de la Obesidad). 20/03/2017-

20/03/2020. 9.000 €.

COL. 

L’impacte del metabolisme energètic en les modificacions epigenètiques derivades de la combinació de la diabetis i obesitat. (La Marató de TV3. IISPV). 01/01/2017-31/12/2019. 200.000 €.

Sabench F, Rusu EC, Clavero-Mestres H, Arredondo-Prats V, Veciana-Molins M, Muñiz-Piera S, Vives M, Aguilar C, Bartra E, París-Sans M, Alibalic A, Quintillà MTA.

Metabolic-Associated Fatty Liver Disease and Weight Loss After Bariatric Surgery: A Systematic Review and Meta-Analysis. Obes Surg. 2024 Nov 19. doi: 10.1007/s11695-024-07585-8. Epub ahead of print. PMID: 39560894. Q1. IF: 2.9

Arto C, Rusu EC, Clavero-Mestres H, Barrientos-Riosalido A, Bertran L, Mahmoudian R, Aguilar C, Riesco D, Chicote JU, Parada D, Martínez S, Sabench F, Richart C, Auguet T.

Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction-associated steatotic liver disease. Eur JClin Invest. 2024 Nov;54(11):e14279. doi: 10.1111/eci.14279. Epub 2024 Jun 28. PMID: 38940215. Q2. IF: 4.4

Gebellí-Jové JT, Buñuel-Viñau A, Canela-Capdevila M, Camps J, Sabench F, Iftimie-Iftimie P.

A prospective, randomized, blinded study on the efficacy of using corticosteroids in hydrodilatation as a treatment for adhesive capsulitis of the shoulder. Shoulder Elbow. 2024 Mar 20:17585732241239030. doi: 10.1177/17585732241239030. Epub ahead of print. PMID: 39552668; PMCID: PMC11565509. Q3. IF: 1.5

Duran-Bertran J, Rusu EC, Barrientos-Riosalido A, Bertran L, Mahmoudian R, Aguilar C, Riesco D, Martínez S, Ugarte Chicote J, Sabench F, Richart C, Auguet T.

Platelet-associated biomarkers in nonalcoholic steatohepatitis: Insights from a female cohort with obesity. Eur J Clin Invest. 2024 Mar;54(3):e14123. doi: 10.1111/eci.14123. Epub 2023 Nov 6. PMID: 37929908. Q2. IF: 4.4

Bertran L, Capellades J, Abelló S, Durán-Bertran J, Aguilar C, Martinez S, Sabench F, Correig X, Yanes O, Auguet T, Richart C.

LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity. Int J Mol Sci. 2023 Jun 6;24(12):9789. doi: 10.3390/ijms24129789. PMID: 37372937; PMCID: PMC10298321. IF: 4.9 Q2

Auguet T, Bertran L, Capellades J, Abelló S, Aguilar C, Sabench F, Del Castillo D, Correig X, Yanes O, Richart C.

LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus.

Int J Mol Sci. 2023 Apr 24;24(9):7761. doi: 10.3390/ijms24097761. PMID: 37175468; PMCID: PMC10177925. IF: 4.9 Q2

Ferrer-Márquez M, Frutos Bernal MD, Ruiz de Gordejuela AG, García-Redondo M, Millán M, Sabench Pereferrer F, Tarascó Palomares J; Grupo ReNacEIBar.

Results of the national registry of patients diagnosed with inflammatory bowel disease candidates for bariatric surgery (ReNacEIBar). Cir Esp (Engl Ed). 2024 Jan;102(1):44-52. doi: 10.1016/j.cireng.2023.05.018. Epub 2023 Nov 10. PMID: 52719.  IF: 1.3 Q3

Bertran L, Adalid L, Vilaró-Blay M, Barrientos-Riosalido A, Aguilar C, Martínez S, Sabench F, Del Castillo D, Porras JA, Alibalic A, Richart C, Auguet T.  

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease. Metabolites. 2023 Mar 29;13(4):496. doi: 10.3390/metabo13040496. PMID: 37110154; PMCID: PMC10146769. IF: 3.5 Q2

Barrientos-Riosalido A, Bertran L, Vilaró-Blay M, Aguilar C, Martínez S, Paris M, Sabench F, Riesco D, Binetti J, Castillo DD, Richart C, Auguet T.

The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease. Int J Mol Sci. 2023 Mar 9;24(6):5221. doi: 10.3390/ijms24065221. PMID: 36982296; PMCID: PMC10049551. IF: 4.9 Q2

Barrientos-Riosalido A, Real M, Bertran L, Aguilar C, Martínez S, Parada D, Vives M, Sabench F, Riesco D, Castillo DD, Richart C, Auguet T.

Increased Hepatic <i>ATG7</i> mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity. Int J Mol Sci. 2023 Jan 10;24(2):1324. doi: 10.3390/ijms24021324. PMID: 36674839; PMCID: PMC9867349. IF: 4.9 Q2

Auguet T, Bertran L, Barrientos-Riosalido A, Fabregat B, Villar B, Aguilar C, Sabench F.

Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease? Int J Environ Res Public Health. 2022 Oct 18;19(20):13495. doi: 10.3390/ijerph192013495. PMID: 36294076; PMCID: PMC9602632. IF: 4.614 Q1

Sabench Pereferrer F.

Revisional bariatric surgery: on stage! Cir Esp (EnglEd). 2023 Feb;101(2):77-79. doi: 10.1016/j.cireng.2022.04.027. Epub 2022 Sep 21. PMID: 36152959.IF: 1.3, Q3

Bertran L, Portillo-Carrasquer M, Barrientos-Riosalido A, Aguilar C, Riesco D, Martínez S, Culebradas A, Vives M, Sabench F, Castillo DD, Richart C, Auguet T. 

Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity. Int J Mol Sci. 2022 Aug 30;23(17):9871. doi: 10.3390/ijms23179871. PMID: 36077270; PMCID: PMC9456439. IF: 5.6 Q2

Cabré N, Luciano-Mateo F, Chapski DJ, Baiges-Gaya G, Fernández-Arroyo S, Hernández-Aguilera A, Castañé H, Rodríguez-Tomàs E, París M, Sabench F, Castillo DD, Del Bas JM, Tomé M, Bodineau C, Sola-García A, López-Miranda J, Martín-Montalvo A, Durán RV, Vondriska TM, Rosa-Garrido M, Camps J, Menéndez JA, Joven J. 

Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis. Int J Mol Sci. 2022 Jul 15;23(14):7830. doi: 10.3390/ijms23147830. PMID: 35887177; PMCID: PMC9320342. IF: 5.6 Q2

Bertran L, Jorba-Martin R, Barrientos-Riosalido A, Portillo-Carrasquer M, Aguilar C, Riesco D, Martínez S, Vives M, Sabench F, Castillo DD, Richart C, Auguet T.

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease. Int J Mol Sci. 2022 Jul 4;23(13):7442. doi: 10.3390/ijms23137442. PMID: 35806447; PMCID: PMC9267292. IF: 5.6 Q2

Sabench F, Bertran L, Vives M, París M, Aguilar C, Martínez S, Binetti J, Real M, Alibalic A, Richart C, Del Castillo D, Auguet T.

NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity. Obes Surg. 2022 Oct;32(10):3313-3323. doi: 10.1007/s11695-022-06175-w. Epub 2022 Jul 6. PMID: 35792995. Q2. IF: 2.9

Rodriguez-Leon G, Estremiana F, Miro M, Bettonica C, Aranda H, Farran L, de Oca J, Sabench F, Jorba R.

Ischemic Conditioning in the Right Colon and Terminal Ileum: An Experimental Rat Model. Eur Surg Res. 2022;63(4):278-284. doi: 10.1159/000520676. Epub 2021 Dec 7. PMID: 34875649. IF: 1.6, Q3

Bertran L, Portillo-Carrasquer M, Martínez S, Aguilar C, Lopez-Dupla M, Riesco D, Binetti J, Vives M, Sabench F, Del Castillo D, Richart C, Auguet T.

Expression of Jejunal Taste Receptors in Women with Morbid Obesity. Nutrients. 2021 Jul 16;13(7):2437. doi:  10.3390/nu13072437. PMID: 34371946; PMCID: PMC8308737. IF: 6.706, Q1

Sánchez Santos R, Garcia Ruiz de Gordejuela A, Breton Lesmes I, Lecube Torelló A, Moizé Arcone V, Arroyo Martin JJ, Fernandez Alsina E, Martín Antona E, Rubio Herrera MÁ, Sabench Pereferrer F, Sánchez Pernaute A, Vilallonga Puy R.

Obesity and SARS-CoV-2: Considerations on bariatric surgery and recommendations for the start of surgical activity. Cir Esp (Engl Ed). 2021 Jan;99(1):4-10. English, Spanish. doi: 10.1016/j.ciresp.2020.06.005. Epub 2020 Jun 18. PMID: 32921419; PMCID: PMC7301111. Q3. IF: 2.242

Beisani M, Sabench Pereferrer F, Vilallonga R, González López Ó, Molina López A, Del Castillo Dejardin D, García Ruiz de Gordejuela A, Fort López-Barajas JM, Armengol Carrasco M; Members of the Obesity Section of the Spanish Surgical Association Collaborative Group.

Seeking an Initial-Weight-Independent Metric in a Mediterranean Cohort of Gastric Bypass Patients: the %AWL Revisited. Obes Surg. 2021 Apr;31(4):1524-1532. doi: 10.1007/s11695-020-05154-3. Epub 2021 Jan 4. PMID: 33398625. Q2. IF: 3.479

Villar B, Bertran L, Aguilar C, Binetti J, Martínez S, Sabench F, Real M, Riesco D, París M, Del Castillo D, Richart C, Auguet T.

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism. Metabolites. 2021 Jun 10;11(6):373. doi: 10.3390/metabo11060373. PMID: 34200577; PMCID: PMC8226510.  IF: 5.581, Q2

Bertran L, Portillo-Carrasquer M, Aguilar C, Porras JA, Riesco D, Martínez S, Vives M, Sabench F, Gonzalez E, Del Castillo D, Richart C, Auguet T.

Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity. Int J Mol Sci. 2021 Jun 27;22(13):6895. doi: 10.3390/ijms22136895. PMID: 34198988; PMCID: PMC8268103. IF: 6.208 Q2

Bertran L, Pastor A, Portillo-Carrasquer M, Binetti J, Aguilar C, Martínez S, Vives M, Sabench F, Porras JA, Riesco D, Del Castillo D, Richart C, Auguet T.

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease. Int J Mol Sci. 2021 May 15;22(10):5239. doi: 10.3390/ijms22105239. PMID: 34063472; PMCID: PMC8156882. IF: 6.208 Q2

Cabré N, Luciano-Mateo F, Chapski DJ, Baiges-Gaya G, Fernández-Arroyo S, Hernández-Aguilera A, Castañé H, Rodríguez-Tomàs E, París M, Sabench F, Del Castillo D, Del Bas JM, Tomé M, Bodineau C, Sola-García A, López-Miranda J, Martín-Montalvo A, Durán RV, Vondriska TM, Rosa-Garrido M, Camps J, Menéndez JA, Joven J.

Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression. J Hepatol. 2021 May 4:S0168-8278(21)00302-0. doi: 10.1016/j.jhep.2021.04.037. Epub ahead of print. PMID: 33961941. IF. 30.083, Q1

Hernández-Aguilera A, Casacuberta N, Castañé H, Fibla M, Fernández-Arroyo S, Fort-Gallifa I, París M, Sabench F, Del Castillo D, Baiges-Gaya G, Rodríguez- Tomàs E, Sans T, Camps J, Joven J.

Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity. Biol Trace Elem Res. 2021 Dec;199(12):4555-4563. doi: 10.1007/s12011-021-02610-8. Epub 2021 Feb 8. PMID: 33559024. IF: 4.081, Q2

Cabré N, Gil M, Amigó N, Luciano-Mateo F, Baiges-Gaya G, Fernández-Arroyo S, Rodríguez-Tomàs E, Hernández-Aguilera A, Castañé H, París M, Sabench F, Del Castillo D, Camps J, Joven J.

Laparoscopic sleeve gastrectomy alters ¹H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease. Sci Rep. 2021 Jan 14;11(1):1343. doi: 10.1038/s41598-020-79485-7. PMID: 33446705; PMCID: PMC7809416. IF: 4.997, Q2

Binetti J, Bertran L, Riesco D, Aguilar C, Martínez S, Sabench F, Porras JA, Camaron J, Castillo DD, Richart C, Auguet T.

Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD. Life (Basel). 2020 Oct 16;10(10):245. doi: 10.3390/life10100245. PMID: 33081272; PMCID: PMC7603041. IF: 3.817, Q2

Ejarque M, Sabadell-Basallote J, Beiroa D, Calvo E, Keiran N, Nuñez-Roa C, Rodríguez MDM, Sabench F, Del Castillo D, Jimenez V, Bosch F, Nogueiras R, Vendrell J, Fernández-Veledo S.

Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function. Br J Pharmacol. 2021 May;178(10):2131-2145. doi: 10.1111/bph.15278. Epub 2020 Nov 19. PMID: 32986861. IF: 9.473, Q1

Parada D D, Peña G KB, Vives M, Molina A, Mayayo E, Riu F, Sabench F, Del Castillo D.

Quantitative and Topographic Analysis by Immunohistochemical Expression of Ghrelin Gastric Cells in Patients with Morbid Obesity. Diabetes Metab Syndr Obes. 2020 Aug 18;13:2855-2864. doi: 10.2147/DMSO.S260483. PMID: 32884313; PMCID: PMC7443401. IF: 3.168, Q3

Sabench Pereferrer F, Molina López A, Acín Gándara D, Arroyo Martín JJ, Baltar Boileve J, Barranco Moreno A, Cassinello Fernández N, Del Castillo Déjardin D, Fernández Alsina E, Ferrer-Márquez M, Mans Muntwyler E, Martín García-Almenta E, García Ruiz de Gordejuela A.

Analysis of mid-term weight loss after Roux-en-Y gastric bypass and sleeve gastrectomy: Proposed percentile charts for total weight loss percentages to be used in daily clinical practice. Cir Esp (Engl Ed). 2020 Feb;98(2):72-78. English, Spanish. doi: 10.1016/j.ciresp.2019.09.008. Epub 2019 Nov 19. PMID: 31757409. IF: 1.653 Q3

Auguet T, Bertran L, Binetti J, Aguilar C, Martínez S, Guiu-Jurado E, Sabench F, Adalid L, Porras JA, Riesco D, Del Castillo D, Richart C. 

Hepatocyte Notch Signaling Deregulation Related to Lipid Metabolism in Women with Obesity and Nonalcoholic Fatty Liver. Obesity (Silver Spring). 2020 Aug;28(8):1487-1493. doi: 10.1002/oby.22873. Epub 2020 Jul 13. PMID: 32657010. IF: 5.002, Q1

Auguet T, Bertran L, Binetti J, Aguilar C, Martínez S, Sabench F, Lopez-Dupla JM, Porras JA, Riesco D, Del Castillo D, Richart C.

Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. Int J Mol Sci. 2020 Jun 11;21(11):4189. doi: 10.3390/ijms21114189. PMID: 32545403; PMCID: PMC7312372. IF: 5.924 Q2

Cabré N, Luciano-Mateo F, Baiges-Gayà G, Fernández-Arroyo S, Rodríguez-Tomàs E, Hernández-Aguilera A, París M, Sabench F, Del Castillo D, López-Miranda J, Menéndez JA, Camps J, Joven J.

Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2020 Feb;51(3):374-387. doi: 10.1111/apt.15606. Epub 2019 Dec 11. PMID: 31825539. IF: 8.171, Q1

Aragonès G, Colom-Pellicer M, Aguilar C, Guiu-Jurado E, Martínez S, Sabench F, Antonio Porras J, Riesco D, Del Castillo D, Richart C, Auguet T.

Circulating microbiota-derived metabolites: a “liquid biopsy? Int J Obes (Lond). 2020 Apr;44(4):875-885. doi: 10.1038/s41366-019-0430-0. Epub 2019 Aug 6. PMID: 31388096; PMCID: PMC7101279. IF: 5.095, Q2

Cabré N, Luciano-Mateo F, Fernández-Arroyo S, Baiges-Gayà G, Hernández-Aguilera A, Fibla M, Fernández-Julià R, París M, Sabench F, Castillo DD, Menéndez JA, Camps J, Joven J.

Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. Metabolism. 2019 Oct;99:81-89. doi: 10.1016/j.metabol.2019.07.002. Epub 2019 Jul 4. PMID: 31279739. IF: 6.159, Q1

Títol: Alteracions en l’expressió del perfil transcripcional dels teixits adiposos visceral i subcutani i del peritoneu visceral en l’obesitat abans i després del bypass gastrojejunal en Y de Roux en un model experimental en rates

Nom doctorand: Laura Caubet Domingo

Any defensa: 2024

Universitat:UAB-URV

Títol: Tractament de la Capsulitis Adhesiva d’Espatlla mitjançant Hidrodilatació. Estudi Randomitzat amb/sense Corticoides Intra-articulars

Nom doctorand: Joan Tomàs Gebellí Jové

Any defensa: 2024

Universitat: URV

Títol: Fractura osteoporótica de cadera. Estudio de factores de riesgo de mortalidad en la población geriátrica

Nom doctorand: Javier García Alba

Any defensa: 2022

Universitat: URV

Títol: Estudio de la expresión de grelina gástrica por inmunohistoquímica en pacientes con obesidad mórbida intervenidas mediante gastrectomía vertical laparoscópica, y su relación con las variaciones plasmáticas de ambas isoformas de grelina

Nom doctorand: David Parada Domínguez

Any defensa: 2018

Universitat: URV

Títol: Efecto de la gastrectomía vertical laparoscópica, con o sin preservación antral, sobre la ingesta y la tolerancia alimentaria, la composición corporal, la respuesta metabólica y las alteraciones nutricionales

Nom doctorand: Alicia Molina López

Any defensa: 2017

Universitat: URV

Títol: Consideracions fisiopatològiques i metabòliques de la gastrectomia vertical amb gastroplàstia tubular laparoscòpica amb o sense preservació antral

Nom doctorand: Margarida Vives Espelta

Any defensa: 2017

Universitat: URV

Títol: “Gastrectomía vertical vs plicatura gástrica en un modelo experimental de obesidad. Efectos metabólicos y ponderales.”

Nom doctorand: Aranzazu Cabrera Vilanova

Any defensa: 2016

Universitat: URV

 Vía Clínica en cirugía bariátrica. 2017. F. Sabench coautora. ISBN: 978-84-697-7104-4.

Sabench F et al:  Consensus review and recommendations of the Spanish Association of Surgeons and the Spanish Society of Bariatric Surgery.Cir Esp. 2017 Jan;95(1):4-16. doi: 10.1016/j.ciresp.2016.09.007.

Consenso GETECCU-SEEDO-AEC-SEED. Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn’s Disease and Ulcerative Colitis.Gastroenterol Hepatol. 2024 Jan 28:S02